US$ 27.73
i took my first dose of semaglutide How to Use Ozempic® Pen Wegovy® Pen Guide and Dosing
Description
Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss
/PRNewswire/ -- FuturHealth, a leading provider of personalized weight-loss solutions, today announced the launch of Affirm (NASDAQ: AFRM), the payment network...

Clear, structured layout for quick daily reference

Researchers are exploring how maintaining a healthy weight impacts MS symptoms and how drugs like metformin, which is used to treat type 2 diabetes, may impact remyelination and inflammation

Asebey and Guilherme Ferrari examine what this means for telehealth and compounding companies

Category: Clinical Trials & Real-World EvidenceWritten and Reviewed By: Pharmacally Medical News DeskAt European Society of Cardiology Congress 2025 in Madrid happening between August 29 to 1 September 2025, Novo Nordisk reported that Wegovy (semaglutide 2.4 mg) was linked to a 57% lower risk of heart attack, stroke, or death compared with tirzepatide in people
